CryoXtract Blog

On the Conference Circuit: The National Biobank Symposium in Berlin

Posted by Jay Champaneri on Dec 11, 2015 7:46:51 AM
CryoXtract is excited to be appearing with distributor German-Cryo in Booth #14 of the 4th Annual Nationales Biobanken-Symposium 2015 in Berlin on December 9th and 10th. The event brings together biobanking professionals from all areas of the field to exchange information and ideas around key topics such as data management, sustainability, and best practices. 
 
Pictured below is Jay Champaneri of CryoXtract with German-Cryo Sales and Marketing Director Thomas Henne. Highlighted in the booth is the CryoXtract CXT 353 frozen sample aliquotter.
 
For more information, please visit the conference website at: 
 
Read More

Topics: biobanks, Conferences

In the Media: The Next Frontier of Biobanking

Posted by Joe Fraone on Aug 19, 2015 2:38:22 PM

A recent article in Genetic Engineering and Biotech News, found here, discusses the necessity of and options for improved biospecimen tracking, procurement, and distribution that extends beyond biobanks alone. The authors emphasize the importance of rich analytical biospecimen data, dynamic sample collection, and efficient sample distribution. With the ultimate goal to propel biobanking forward in order to efficiently support the advancement of personalized medicine, frozen aliquotting technology’s ability to preserve biospecimen integrity and increase utilization is key to this goal.

Read More

Topics: biobanks, biobanking, personalized medicine

In the media: Individual Investigator Profiles of Biospecimen Use in Cancer Research

Posted by Larry Chin on Jul 15, 2014 7:14:41 AM

Authors of a recent study in Biopreservation and Biobanking analyze patterns of biospecimen use in the cancer research of three individual investigators. To review the June 2014 abstract and purchase the article, click here.

Read More

Topics: biobanks, Press Summaries

Listen to the Audio: Interview with Dee McGarvey, Director, CHTN Eastern Division, University of PA

Posted by Larry Chin on May 23, 2014 9:11:00 AM

The following are indexed audio files of the full interview between Larry Chin, Vice President of Business Development at CryoXtract, and Dee McGarvey, Director, CHTN Eastern Division, University of Pennsylvania.

Read More

Topics: Sample Integrity, ISBER, legacysamples, biobanks, biobanking

Listen to the Audio: Interview with Andy Zaayenga, Managing Director of SmarterLab and President-Elect of ISBER, 2014-2015

Posted by Larry Chin on May 2, 2014 8:14:05 AM

The following are audio files of the full interview conducted by Larry Chin, Vice President of Business Development at CryoXtract, with Andy Zaayenga, Managing Director of SmarterLab and President-Elect of ISBER, 2014-2015. You can also read the full transcript below.

Challenges Facing the Biobanking Industry:

In a recent interview with CryoXtract’s Larry Chin, Andy Zaayenga, Managing Director of SmarterLab and incoming President of ISBER, discusses the top three challenges facing the biobanking industry today. He cites problems with sample utilization and acceptance of biobanks by the general population as key concerns. Both of these relate to the third problem of biobanks operating alone in silos. Without solid systems of communication and standardization of infrastructure and procedures, improving sample utilization and the public perception of the industry is difficult. ISBER is one organization working towards addressing these issues through initiatives such as its upcoming biorepository locator.

Needs of the Biobanking Industry:

Andy Zaayenga continues his discussion of the top three gaps and unmet needs of biobanks by arguing for improved quality assurance and control in order to preserve sample suitability for research. He again calls for standardization and harmonization of quality assurance procedures, data structures, and annotation of samples to increase accessibility and cross-utilization of samples.  Finally, he highlights ISBER's published best practices and self-assessment tools as key answers to another major gap in the industry. 

Read More

Topics: ISBER, Andy Zaayenga, biospecimens, legacysamples, biobanks, biorepository, biobanking